- Home
- LGND vs SDGR Comparison
LGND vs SDGR Comparison
Compare LGND & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGND
- SDGR
- Stock Information
- Founded
- LGND 1987
- SDGR 1990
- Country
- LGND United States
- SDGR United States
- Employees
- LGND N/A
- SDGR N/A
- Industry
- LGND Biotechnology: Pharmaceutical Preparations
- SDGR Biotechnology: Pharmaceutical Preparations
- Sector
- LGND Health Care
- SDGR Health Care
- Exchange
- LGND Nasdaq
- SDGR Nasdaq
- Market Cap
- LGND 2.2B
- SDGR 1.8B
- IPO Year
- LGND 1992
- SDGR 2020
- Fundamental
- Price
- LGND $120.67
- SDGR $22.64
- Analyst Decision
- LGND Strong Buy
- SDGR Buy
- Analyst Count
- LGND 6
- SDGR 9
- Target Price
- LGND $145.00
- SDGR $32.11
- AVG Volume (30 Days)
- LGND 79.6K
- SDGR 1.0M
- Earning Date
- LGND 02-27-2025
- SDGR 02-26-2025
- Dividend Yield
- LGND N/A
- SDGR N/A
- EPS Growth
- LGND 160.46
- SDGR N/A
- EPS
- LGND 2.47
- SDGR N/A
- Revenue
- LGND $152,422,000.00
- SDGR $193,348,000.00
- Revenue This Year
- LGND $26.86
- SDGR N/A
- Revenue Next Year
- LGND $14.95
- SDGR $31.43
- P/E Ratio
- LGND $48.82
- SDGR N/A
- Revenue Growth
- LGND N/A
- SDGR N/A
- 52 Week Low
- LGND $67.72
- SDGR $16.67
- 52 Week High
- LGND $129.90
- SDGR $33.63
- Technical
- Relative Strength Index (RSI)
- LGND 59.36
- SDGR 43.67
- Support Level
- LGND $110.42
- SDGR $23.14
- Resistance Level
- LGND $119.26
- SDGR $28.47
- Average True Range (ATR)
- LGND 3.82
- SDGR 1.60
- MACD
- LGND 0.61
- SDGR -0.34
- Stochastic Oscillator
- LGND 81.35
- SDGR 9.19
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
About SDGR Schrodinger Inc.
Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.